Dr. Reddy's Laboratories Limited (RDY) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 15.44B | 10.91B | 15.57B | 14.63B | 22B | 6.62B | 9.32B | 8.5B | 136.19M | 53.15M | 17.93B | 11.25B |
| Operating CF Margin % | 20.22% | 12.5% | 17.69% | 17.12% | 25.86% | 7.92% | 11.62% | 11.07% | 0.19% | 0.07% | 2154.05% | 16.7% |
| Operating CF Growth % | -29.82% | 64.77% | 67.16% | 72.19% | 16050.72% | 12354.31% | -48.03% | -24.48% | -99.31% | -99.77% | 93.15% | 69.05% |
| Net Income | 2.24B | 11.9B | 14.27B | 14.1B | 15.87B | 14.04B | 13.41B | 13.92B | 157.4M | 165.6M | 14.8B | 14.03B |
| Depreciation & Amortization | 5.66B | 5.21B | 5.05B | 4.76B | 4.55B | 4.72B | 3.98B | 3.81B | 44.7M | 45.28M | 3.79B | 3.57B |
| Stock-Based Compensation | 0 | 20M | 100M | 112M | 113M | 103M | 107M | 101M | 0 | 0 | 103M | 108M |
| Deferred Taxes | 0 | 3.53B | 4.08B | 4.95B | 4.18B | 4.7B | 5.75B | 4.9B | 0 | 0 | 4.33B | 4.44B |
| Other Non-Cash Items | -239.42M | -1.63B | -5.37B | -1.1B | -3.31B | -7.3B | -6.15B | -1.09B | -32.65M | -14.66M | -7.71B | -2.72B |
| Working Capital Changes | 7.78B | -8.13B | -2.56B | -8.19B | 584M | -9.65B | -7.78B | -13.14B | -33.26M | -143.06M | 2.61B | -8.17B |
| Change in Receivables | 3.57B | -2.35B | -2.88B | -4.81B | 1.75B | -7.85B | -3.4B | -786M | -23.12M | -106.83M | 7.34B | -4.65B |
| Change in Inventory | 1.91B | -2.16B | -2.04B | -6.15B | -363M | -1.06B | -5.01B | -6.32B | -47.05M | -62.47M | -4.7B | -4.64B |
| Change in Payables | -4.69B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -18.13M | 4.5M | 0 | 4.65B |
| Cash from Investing | -28.22B | -10.29B | -9.54B | -19.19B | -13.3B | -5.46B | -19.07B | -20.25B | -142.11M | -198.76M | -4.52B | -8.24B |
| Capital Expenditures | -11.29B | -6.7B | -5.22B | -6.86B | -7.66B | -7.2B | -7.54B | -5.11B | -75.78M | -60.21M | -3.68B | -12.17B |
| CapEx % of Revenue | 14.79% | 7.68% | 5.93% | 8.03% | 9.01% | 8.61% | 9.4% | 6.66% | 0.11% | 0.08% | 442.68% | 18.06% |
| Acquisitions | -3.17B | 0 | 0 | -51M | -1.66B | 0 | -51.76B | 0 | 633.69K | 6.31M | 0 | 12.17B |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 1.08B | -105M | -4.64B | -2.42B | -2.22B | -485M | 1.09B | -668M | -139 | -968 | 915M | -11.79B |
| Cash from Financing | 8.74B | 7.78B | -5.32B | -1.2B | -7.37B | 590M | 16.15B | 9.54B | 1.7M | 70.75M | -7.04B | -1.48B |
| Debt Issued (Net) | 9.04B | 8.68B | 2.37B | -256M | -5.15B | 1.52B | 16.55B | 10.27B | 4.5M | 74.66M | -587M | -991M |
| Equity Issued (Net) | 81.68M | 30M | 92M | 196M | -8.43B | 25M | 7.19B | 19M | 369.44K | 73.53K | 686M | 79M |
| Dividends Paid | 41.14M | 0 | -6.66B | 0 | 0 | 0 | -6.66B | 0 | 44.06K | 306.57K | -6.65B | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -1.39B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -428.84M | -936M | -1.12B | -1.14B | 6.21B | -956M | -937M | -744M | -3.21M | -4.29M | -487M | -564M |
| Net Change in Cash | -4.23B | 8.75B | 902M | -5.59B | 1.56B | 1.75B | 6.37B | -2.19B | -5.34M | -72.49M | 6.31B | 1.45B |
| Free Cash Flow | 10.75B | 3.59B | 5.44B | 4.48B | 10.75B | -2.2B | 1.41B | 2.07B | 72.9M | 7.12M | 13.99B | -921M |
| FCF Margin % | 14.08% | 4.11% | 6.18% | 5.24% | 12.64% | -2.63% | 1.76% | 2.7% | 0.1% | 0.01% | 1680.73% | -1.37% |
| FCF Growth % | -0.01% | 263.17% | 286.5% | 116.31% | 14645.5% | -30998.76% | -89.94% | 324.97% | -99.54% | -99.96% | 135% | 54.74% |
| FCF per Share | 12.88 | 4.31 | 6.53 | 5.38 | 12.89 | -2.64 | 1.69 | 2.48 | 0.09 | 0.01 | 16.78 | -1.11 |
| FCF Conversion (FCF/Net Income) | 6.91x | 0.90x | 1.08x | 1.03x | 1.38x | 0.47x | 0.74x | 0.61x | 0.01x | 0.00x | 100.14x | 0.80x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |